Devyser launches two new genetic testing solutions for hereditary cancer
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Hereditary cancer | December 16, 2024
Webinar recap: Implementing Devyser BRCA to evaluate hereditary cancer risk
Hereditary cancers, particularly breast and ovarian cancers, pose a significant risk for many individuals with inherited genetic mutations. Detecting these genetic variants early can profoundly...
Find out more
